|
Volumn 285, Issue 5428, 1999, Pages 674-676
|
Lentiviral vectors - The promise of gene therapy within reach?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENO ASSOCIATED VIRUS;
CANCER RISK;
EXPRESSION VECTOR;
GENE TARGETING;
GENE THERAPY;
GENE TRANSFER;
GENETIC DISORDER;
HEMOPHILIA B;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LENTIVIRINAE;
NONHUMAN;
PRIORITY JOURNAL;
RECOMBINANT DNA TECHNOLOGY;
RETINITIS PIGMENTOSA;
SAFETY;
SHORT SURVEY;
STEM CELL;
VIRUS GENOME;
VIRUS RECOMBINANT;
ANIMALS;
CELL LINE;
GENE THERAPY;
GENE TRANSFER TECHNIQUES;
GENES, VIRAL;
GENETIC VECTORS;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HEMATOPOIETIC STEM CELLS;
HIV;
HIV INFECTIONS;
HUMANS;
LENTIVIRUS;
MUTAGENESIS, INSERTIONAL;
PLASMIDS;
RECOMBINATION, GENETIC;
RETINITIS PIGMENTOSA;
TRANSFECTION;
VIRUS REPLICATION;
ADENO-ASSOCIATED VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS;
LENTIVIRUS;
|
EID: 0033618547
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.285.5428.674 Document Type: Short Survey |
Times cited : (156)
|
References (21)
|